Cheston J. Larson | Wiki & Bio | Everipedia, the encyclopedia of everything

Cheston J. Larson

Cheston Larson serves as Chair of the office's Emerging Companies Practice and is Co-chair of the firm’s Life Sciences Industry group. His practice covers a range of general corporate matters, including counseling public and privately-held companies as well as representing venture capital and investment banking firms in private and public financing transactions.

Mr. Larson advises clients on the formation of new businesses and their capital raising transactions, spanning the spectrum from angel and venture financings to IPOs, follow-on offerings, PIPEs and debt financing. He also regularly represents clients in mergers and acquisitions and other strategic transactions. Mr. Larson has extensive experience in SEC disclosure and reporting requirements, Nasdaq and NYSE compliance, and management compensation and equity incentive matters.

Mr. Larson routinely counsels clients in the life sciences, software, telecommunications, cleantech and other technology industries. 

Mr. Larson was recognized in Chambers USA 2015 for his work in Capital Markets: Debt & Equity, and as an “Up & Coming” lawyer in California – Life Sciences. In 2015, Best Lawyers in America named him "Lawyer of the Year" and selected him for inclusion in the 2013 & 2014 editions as a recommended attorney in Securities/Capital Markets Law. The Legal 500 US 2015 recognized Mr. Larson as having "notable expertise in early-stage finance," and in 2012, he was named a recommended attorney in the area of Venture Capital and Emerging Companies. Most recently, LMG Euromoney Life Sciences 2015 recognized Mr. Larson as a "Life Sciences Star" in Finance and Transactional. He was recommended as one of the Top 20 California lawyers under the age of 40 by the Daily Journal and he is recognized among San Diego's top corporate attorneys by Super Lawyers and San Diego Magazine. In law school, Mr. Larson was an editor of the Harvard Law Review and worked for the US Securities and Exchange Commission's Enforcement Division as part of Harvard's Clinical Practice Program.

Recent Speaking Engagements
  • Panelist, “Being Public – The Advisors,” PwC – Planning a Successful IPO – Going and Being Public, November 2015
  • Moderator, "From Readiness to Roadshow: The Path to a Successful IPO," Biocom's Global Life Sciences Partnering Conference, February 2015
  • Panelist, “From the Trenches: Are You Ready to IPO?” Janssen Labs, November 2014
  • Instructor, "'What are the rules? - The Director and Securities Law," Corporate Directors Forum's Governance Academy, May 2014
  • Panelist, “IPO Execution,” IPO Bootcamp, April 2014